Please assess the completion status of the following clinical trial:

Trial Title: A Study for the Treatment of Painful Diabetic Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients at least 18 years of age.~* Patients with pain due to diabetic neuropathy in both legs.~* Females must not be pregnant or plan to become pregnant during the study.~* Stable Glycemic control.~* Average mean pain severity score of at least 4.0 as assessed by completion of a daily diary.~Exclusion Criteria:~* You are related to or work for the physician conducting the study or are employed by Eli Lilly and Company.~* You have a severe or serious medical condition that causes you to be hospitalized often; or you have had a kidney transplant or are on current dialysis.~* You have participated in a study for an investigational drug within the last 30 days.~* You have a history of major depressive disorder, generalized anxiety disorder, or alcohol or eating disorders.~* You have a past medical history or diagnosis of mania, bipolar disorder, or psychosis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).